Skip to main content
MB

Multiplex.bio

Multiplex.bio offers advanced molecular diagnostics for plant viruses and viroids using high-throughput sequencing and its proprietary Viroscope™ algorithm. This platform provides high diagnostic certainty by correlating viral genome coverage with biological infectivity, ensuring accurate detection for plant health management.

Santiago, ChileFounded 202191K+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Diagnosing plant viruses and viroids using high-throughput sequencing (HTS) data presents significant challenges in achieving accurate and reliable results. Traditional methods often struggle with differentiating true pathogen presence from experimental noise, leading to diagnostic uncertainty and delayed decision-making in plant health management.

Solution

Multiplex.bio provides advanced molecular diagnostics for plant phytosanitation, leveraging multiplex PCR and HTS. Their proprietary Viroscope™ algorithm offers functional detection of viruses and viroids, providing high diagnostic certainty by correlating viral genome coverage with biological infectivity. This approach establishes objective criteria to distinguish pathogens from noise, ensuring high sensitivity and specificity with a negligible false discovery rate. The platform utilizes state-of-the-art robotic automation for scalable library preparation and HTS platforms for enhanced detection sensitivity. Multiplex.bio delivers timely, biologically-informed reports to support critical decision-making in plant health.

Target Audience

The primary customers are agricultural professionals, plant pathologists, and research institutions requiring precise and reliable molecular diagnostics for plant viral and viroid detection.

Features

  • Viroscope™ algorithm for functional detection of plant viruses and viroids from HTS data.
  • Objective detection criteria derived from correlating viral genome coverage with biological infectivity.
  • High sensitivity and specificity with a negligible false discovery rate.
  • Utilization of multiplex PCR and high-throughput sequencing technologies.
  • Robotic automation for scalable and cost-effective library preparation.
  • Bioinformatics analysis to identify biological features and discern pathogen infectivity.
  • Delivery of timely, biologically-informed diagnostic reports.
This profile is AI-generated and may contain inaccuracies.